Pfizer and BioNTech seek full vaccine approval for those ages 12-15
The Hill (12/16) reports that Pfizer and BioNTech announced on Thursday evening that they had submitted an application to the Food and Drug Administration (FDA) seeking full approval for the administration of their two-dose COVID-19 vaccine in children aged between 12 and 15. The companies said in a release that their application included follow-up data […]
